Delivery Order SPE2DB22D3011-SPE2DB24FQ2ZF
Award Date
8/2/24
Potential Completion Date
8/5/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4 mg ondansetron hydrochloride tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that holds a single-award Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and...
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets to the Defense Logistics Agency (DLA). The $1,625.81 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of October 23, 2024 and was awarded on October 22, 2024. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop...
This federal contract award is for the delivery of Ondansetron HCL 4 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,806.71 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on December 4, 2023, with a completion date of December 5, 2023. The award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
This federal contract award is for the delivery of Ondansetron HCL 4 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $32,573.01 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 16, 2024. The contract has an ultimate completion date of September 17, 2024 and is not set aside for any specific business type. This order is likely part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $2,734.61 for the supply of Ondansetron HCL 4 mg tablets. The award was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and does not utilize any set-aside designations. The contract has an ultimate completion date of September 25, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award is for the delivery of 4,566,165,480 units of ondansetron HCL 4 mg tablets to the Defense Logistics Agency (DLA). The firm-fixed-price delivery order, valued at $22,056.48, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 21, 2024, with a completion date of October 22, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of Ondansetron ODT 4 mg tablets in 30-tablet packages to the Defense Logistics Agency (DLA) Troop Support Medical. The award to the prime contractor, Amerisourcebergen Drug Corp, Corporate Office Division, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a comprehensive range of...
This federal contract award is for the delivery of Ondansetron HCL 4 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $2,869.45 firm fixed-price contract was awarded on June 7, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a completion date of June 10, 2024. The contract is a delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of 4,563,337,505 units of Ondansetron HCL 4 mg tablets to the Defense Logistics Agency (DLA). The $3,198.52 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on January 16, 2024 with a completion date of January 17, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This...
This federal contract award is for the delivery of ondansetron hydrochloride 4 mg tablets to the Defense Logistics Agency (DLA) on a firm fixed-price basis. The contract, valued at $1,386.02, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with an ultimate completion date of September 4, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November...